Review of particle physics
S Eidelman, KG Hayes, KA Olive, M Aguilar-Benitez… - Physics letters B, 2004 - Elsevier
This biennial Review summarizes much of Particle Physics. Using data from previous
editions, plus 1726 new measurements from 512 papers, we list, evaluate, and average …
editions, plus 1726 new measurements from 512 papers, we list, evaluate, and average …
[HTML][HTML] Genome-wide association studies
Genome-wide association studies (GWAS) test hundreds of thousands of genetic variants
across many genomes to find those statistically associated with a specific trait or disease …
across many genomes to find those statistically associated with a specific trait or disease …
Review of particle physics
M Tanabashi, PD Grp, K Hagiwara, K Hikasa… - Physical Review …, 2018 - ricerca.sns.it
The Review summarizes much of particle physics and cosmology. Using data from previous
editions, plus 2,873 new measurements from 758 papers, we list, evaluate, and average …
editions, plus 2,873 new measurements from 758 papers, we list, evaluate, and average …
Review of particle physics
C Patrignani, K Agashe, G Aielli, C Amsler, M Antonelli… - 2016 - openaccess.inaf.it
The Review summarizes much of particle physics and cosmology. Using data from previous
editions, plus 3,062 new measurements from 721 papers, we list, evaluate, and average …
editions, plus 3,062 new measurements from 721 papers, we list, evaluate, and average …
[HTML][HTML] Multisystem inflammatory syndrome in US children and adolescents
LR Feldstein, EB Rose, SM Horwitz… - … England Journal of …, 2020 - Mass Medical Soc
Background Understanding the epidemiology and clinical course of multisystem
inflammatory syndrome in children (MIS-C) and its temporal association with coronavirus …
inflammatory syndrome in children (MIS-C) and its temporal association with coronavirus …
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
A Hauschild, JJ Grob, LV Demidov, T Jouary… - The Lancet, 2012 - thelancet.com
Background Dabrafenib, an inhibitor of mutated BRAF, has clinical activity with a
manageable safety profile in studies of phase 1 and 2 in patients with BRAF V600-mutated …
manageable safety profile in studies of phase 1 and 2 in patients with BRAF V600-mutated …
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
Attention deficit/hyperactivity disorder (ADHD) is a highly heritable childhood behavioral
disorder affecting 5% of children and 2.5% of adults. Common genetic variants contribute …
disorder affecting 5% of children and 2.5% of adults. Common genetic variants contribute …
Femtosecond X-ray protein nanocrystallography
X-ray crystallography provides the vast majority of macromolecular structures, but the
success of the method relies on growing crystals of sufficient size. In conventional …
success of the method relies on growing crystals of sufficient size. In conventional …
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
N Concin, X Matias-Guiu, I Vergote, D Cibula… - International Journal of …, 2021 - ijgc.bmj.com
A European consensus conference on endometrial carcinoma was held in 2014 to produce
multi-disciplinary evidence-based guidelines on selected questions. Given the large body of …
multi-disciplinary evidence-based guidelines on selected questions. Given the large body of …
[HTML][HTML] Improved overall survival in melanoma with combined dabrafenib and trametinib
C Robert, B Karaszewska, J Schachter… - … England Journal of …, 2015 - Mass Medical Soc
Background The BRAF inhibitors vemurafenib and dabrafenib have shown efficacy as
monotherapies in patients with previously untreated metastatic melanoma with BRAF V600E …
monotherapies in patients with previously untreated metastatic melanoma with BRAF V600E …